Genome-wide case-control study of musculoskeletal adverse events and functional genomics in women receiving aromatase inhibitors: Going beyond associations

James N. Ingle

doi:10.1186/bcr2746

Genome-wide case-control study of musculoskeletal adverse events and functional genomics in women receiving aromatase inhibitors: Going beyond associations

James N. Ingle

Medical Oncology

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Original language	English (US)
Article number	S17
Journal	Breast Cancer Research
Volume	12
Issue number	SUPPL. 4
DOIs	https://doi.org/10.1186/bcr2746
State	Published - Dec 20 2010

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1186/bcr2746

Cite this

@article{427ba38ca81f4f5bb1b305daf26f5299,

title = "Genome-wide case-control study of musculoskeletal adverse events and functional genomics in women receiving aromatase inhibitors: Going beyond associations",

author = "Ingle, {James N.}",

note = "Funding Information: Supported in part by NIH grants U01GM61388, U01GM63173, P50CA116201, U10CA77202, CCS 015469 from the Canadian Cancer Society, the Biobank Japan Project funded by the Ministry of Education, Culture, Sports, Science and Technology, Japan, and the Breast Cancer Research Foundation. The MA.27 trial, from which the patients in this study were obtained, was supported in part by Pfizer, Inc.",

year = "2010",

month = dec,

day = "20",

doi = "10.1186/bcr2746",

language = "English (US)",

volume = "12",

journal = "Breast Cancer Research",

issn = "1465-5411",

publisher = "BioMed Central",

number = "SUPPL. 4",

}

TY - JOUR

T1 - Genome-wide case-control study of musculoskeletal adverse events and functional genomics in women receiving aromatase inhibitors

T2 - Going beyond associations

AU - Ingle, James N.

N1 - Funding Information: Supported in part by NIH grants U01GM61388, U01GM63173, P50CA116201, U10CA77202, CCS 015469 from the Canadian Cancer Society, the Biobank Japan Project funded by the Ministry of Education, Culture, Sports, Science and Technology, Japan, and the Breast Cancer Research Foundation. The MA.27 trial, from which the patients in this study were obtained, was supported in part by Pfizer, Inc.

PY - 2010/12/20

Y1 - 2010/12/20

UR - http://www.scopus.com/inward/record.url?scp=78650917071&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650917071&partnerID=8YFLogxK

U2 - 10.1186/bcr2746

DO - 10.1186/bcr2746

M3 - Article

C2 - 21172079

AN - SCOPUS:78650917071

SN - 1465-5411

VL - 12

JO - Breast Cancer Research

JF - Breast Cancer Research

IS - SUPPL. 4

M1 - S17

ER -

Genome-wide case-control study of musculoskeletal adverse events and functional genomics in women receiving aromatase inhibitors: Going beyond associations

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this